EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Can antibody conjugated nanomicelles alter the prospect of antibody targeted therapy against schistosomiasis mansoni?

Eglal I Amer, Sonia R Allam, Aceel Y Hassan iD, Esmail M El-Fakharany, Mona M Agwa, Sherine N Khattab, Eman Sheta, Marwa H El-Faham

PLOS Neglected Tropical Diseases · 2023

DOI: 10.1371/journal.pntd.0011776 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2023. Verfasst von Eglal I Amer und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Parasitology, Faculty of Medicine, Alexandria University, Alexandria, Egypt. Hauptthemen laut MEDLINE: Schistosomiasis mansoni, Schistosomiasis, Schistosomicides. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 176 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background CLA (conjugated linoleic acid)-mediated activation of the schistosome tegument-associated sphingomyelinase and consequent disruption of the outer membrane might allow host antibodies to access the apical membrane antigens. Here, we investigated a novel approach to enhance specific antibody delivery to concealed surface membrane antigens of Schistosoma mansoni utilising antibody-conjugated-CLA nanomicelle technology. Methodology/Principal findings We invented and characterised an amphiphilic CLA-loaded whey protein co-polymer (CLA-W) as an IV injectable protein nanocarrier. Rabbit anti- Schistosoma mansoni infection (anti-SmI) and anti- Schistosoma mansoni alkaline phosphatase specific IgG antibodies were purified from rabbit sera and conjugated to the surface of CLA-W co-polymer to form antibody-conjugated-CLA-W nanomicelles (Ab-CLA-W). We investigated the schistosomicidal effects of CLA-W and Ab-CLA-W in a mouse model of Schistosoma mansoni against early and late stages of infection. Results showed that conjugation of nanomicelles with antibodies, namely anti-SmI, significantly enhanced the micelles’ schistosomicidal and anti-pathology activities at both the schistosomula and adult worm stages of the infection resulting in 64.6%-89.9% reductions in worm number; 72.5–94% and 66.4–85.2% reductions in hepatic eggs and granulomas, respectively. Treatment induced overall improvement in liver histopathology, reducing granuloma size and fibrosis and significantly affecting egg viability. Indirect immunofluorescence confirmed CLA-W-mediated antigen exposure on the worm surface. Electron microscopy revealed extensive ultrastructural damage in worm tegument induced by anti-SmI-CLA-W. Conclusion/Significance The novel antibody-targeted nano-sized CLA delivery system offers great promise for treatment of Schistosoma mansoni infection and control of its transmission. Our in vivo observations confirm an immune-mediated enhanced effect of the schistosomicidal action of CLA and hints at the prospect of nanotechnology-based immunotherapy, not only for schistosomiasis, but also for other parasitic infections in which chemotherapy has been shown to be immune-dependent. The results propose that the immunodominant reactivity of the anti-SmI serum, Schistosoma mansoni fructose biphosphate aldolase, SmFBPA, merits serious attention as a therapeutic and vaccine candidate.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Schistosomiasis mansoniSchistosomiasisSchistosomicidesMiceAnimalsRabbitsSchistosoma mansoniAntibodies, HelminthPolymersAntigens, Helminth

Substanzen

Antibodies, HelminthSchistosomicidesPolymersAntigens, Helminth

Autor:innen und Institutionen

  • Department of Medical Parasitology, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
  • Protein Research Department, Genetic Engineering and Biotechnology Research Institute (GEBRI), City of Scientific Research and Technological Applications (SRTA-City), New Borg EL-Arab, Alexandria, Egypt.
  • Department of Chemistry of Natural and Microbial Products, Pharmaceutical and Drug Industries Research Institute, National Research Centre, Dokki, Giza, Egypt.
  • Chemistry Department, Faculty of Science, Alexandria University, Alexandria, Egypt.
  • Department of Pathology, Faculty of Medicine, Alexandria University, Alexandria, Egypt.

ORCID-Profile: Aceel Y Hassan

Zitieren

APA

Amer, E. I., Allam, S. R., Hassan, A. Y., El-Fakharany, E. M., Agwa, M. M., Khattab, S. N., Sheta, E., & El-Faham, M. H. (2023). Can antibody conjugated nanomicelles alter the prospect of antibody targeted therapy against schistosomiasis mansoni?. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0011776

Vancouver

Amer EI, Allam SR, Hassan AY, El-Fakharany EM, Agwa MM, Khattab SN, et al. Can antibody conjugated nanomicelles alter the prospect of antibody targeted therapy against schistosomiasis mansoni?. PLOS Neglected Tropical Diseases. 2023. doi:10.1371/journal.pntd.0011776

BibTeX
@article{Amer2023,
  author = {Amer, Eglal I and Allam, Sonia R and Hassan, Aceel Y and El-Fakharany, Esmail M and Agwa, Mona M and Khattab, Sherine N and Sheta, Eman and El-Faham, Marwa H},
  title = {Can antibody conjugated nanomicelles alter the prospect of antibody targeted therapy against schistosomiasis mansoni?},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2023},
  doi = {10.1371/journal.pntd.0011776}
}
Kostenlos starten →